Sargent Bickham Lagudis’s bluebird bio BLUE Stock Holding History

Sargent Bickham Lagudis’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8	Closed	-$2K	–	957
2021 Q3	$2K	Hold	8	–	–	﹤0.01%	879
2021 Q2	$3K	Buy	+8	New	+$3.17K	﹤0.01%	834
2020 Q4	–	Sell	-9	Closed	-$6K	–	879
2020 Q3	$6K	Hold	9	–	–	﹤0.01%	635
2020 Q2	$7K	Hold	9	–	–	﹤0.01%	611
2020 Q1	$5K	Hold	9	–	–	﹤0.01%	638
2019 Q4	$10K	Hold	9	–	–	﹤0.01%	608
2019 Q3	$10K	Hold	9	–	–	﹤0.01%	556
2019 Q2	$14K	Sell	9 -7	-44%	-$12.1K	﹤0.01%	545
2019 Q1	$34K	Buy	16 +7	+78%	+$12.3K	﹤0.01%	436
2018 Q4	$11K	Hold	9	–	–	﹤0.01%	567
2018 Q3	$16K	Hold	9	–	–	﹤0.01%	534
2018 Q2	$18K	Hold	9	–	–	﹤0.01%	505
2018 Q1	$19K	Hold	9	–	–	﹤0.01%	480
2017 Q4	$20K	Hold	9	–	–	﹤0.01%	492
2017 Q3	$16K	Hold	9	–	–	﹤0.01%	533
2017 Q2	$12K	Hold	9	–	–	﹤0.01%	543
2017 Q1	$10K	Hold	9	–	–	﹤0.01%	589
2016 Q4	$7K	Hold	9	–	–	﹤0.01%	598
2016 Q3	$8	Hold	9	–	–	﹤0.01%	595
2016 Q2	$5K	Hold	9	–	–	﹤0.01%	602
2016 Q1	$5K	Buy	+9	New	+$5.53K	﹤0.01%	623

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sargent Bickham Lagudis's BLUE Position: Q4 2021 in Review

Sargent Bickham Lagudis sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 8 shares — an estimated $2K sold.

Sargent Bickham Lagudis first reported a position in BLUE in Q1 2016 and held it in 21 quarters. The position peaked at $34K in Q1 2019. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

Sargent Bickham Lagudis reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
Sargent Bickham Lagudis sold 8 bluebird bio shares in Q4 2021, an estimated $2K.
Sargent Bickham Lagudis first reported a position in bluebird bio in Q1 2016 and held it in 21 quarters.
Sargent Bickham Lagudis's bluebird bio position peaked at $34K in Q1 2019.
172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2021, filed 18 Jan 2022.